Fluoxetine increases brain MeCP2 immuno-positive cells in a female Mecp2 heterozygous mouse model of Rett syndrome through endogenous serotonin
Abstract Motor skill deficit is a common and invalidating symptom of Rett syndrome (RTT), a rare disease almost exclusively affecting girls during the first/second year of life. Loss-of-function mutations of the methyl-CpG-binding protein2 (MECP2; Mecp2 in rodents) gene is the cause in most patients...
Main Authors: | Claudia Villani, Mirjana Carli, Anna Maria Castaldo, Giuseppina Sacchetti, Roberto William Invernizzi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-94156-x |
Similar Items
-
MeCP2: The Genetic Driver of Rett Syndrome Epigenetics
by: Katrina V. Good, et al.
Published: (2021-01-01) -
Structural investigation of Rett-inducing MeCP2 mutations
by: Ottavia Spiga, et al.
Published: (2019-03-01) -
The Molecular Functions of MeCP2 in Rett Syndrome Pathology
by: Osman Sharifi, et al.
Published: (2021-04-01) -
MeCP2_e2 partially compensates for lack of MeCP2_e1: A male case of Rett syndrome
by: Ryo Takeguchi, et al.
Published: (2020-02-01) -
MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome
by: Derek J. C. Tai, et al.
Published: (2016-02-01)